Editor
Jonathan Raa | Nurphoto | Getty Images
Elon Musk’s neurotech startup Neuralink will begin recruiting patients for its first in-human clinical trial, the company announced in a
Neuralink said in the post Tuesday that its study, called the PRIME Study, is officially seeking patients since it received approval from an independent institutional review board and a hospital site. It’s the next step on Neuralink’s long road to market, and…
